Results 261 to 270 of about 77,428 (296)

Targeting the bacterial stringent response to combat human pathogens. [PDF]

Front Immunol
Gąsior F, Bryszkowska K, Klasa W, Potrykus K.   +3 more
europepmc   +1 more source

An Antibody-Recruiting Molecule Enhances Fcγ Receptor-Mediated Uptake and Killing of Mycobacterial Pathogens by Macrophages. [PDF]

ACS Infect Dis
Dzigba P, Dekhtyar GAT, Hartman MJ, Winstead-Leroy KJ, Greenlee-Wacker MC, Swarts BM.   +5 more
europepmc   +1 more source

Immunoregulation by ESAT-6: From Pathogenesis of Tuberculosis to Potential Anti-Inflammatory and Anti-Rejection Application. [PDF]

Pharmaceuticals (Basel)
Lu W, Lin J, He Y, Yang B, Qiu F, Dai Z.
europepmc   +1 more source

Evaluation of the Standard M10 MTB/NTM Molecular Test for the Rapid Identification of Tuberculous and Nontuberculous Mycobacteria in Liquid Cultures. [PDF]

Pathogens
Caldrer S, Carrara A, Ragusa A, Nicolini L, Pomari E, Mazzi C, Formenti F, Perandin F.   +7 more
europepmc   +1 more source

Diagnosis of nontuberculous mycobacterial infections using genomics and artificial intelligence-machine learning approaches: scope, progress and challenges. [PDF]

Front Microbiol
Murthy MK, Gupta VK, Maurya AP.
europepmc   +1 more source

Slowly Growing Mycobacteriaの分類と同定 第1報

, 1966
束村 道雄, 束村 純雄
openalex   +1 more source

THE ENVELOPE OF MYCOBACTERIA [PDF]

Annual Review of Biochemistry, 1995
Mycobacteria, members of which cause tuberculosis and leprosy, produce cell walls of unusually low permeability, which contribute to their resistance to therapeutic agents. Their cell walls contain large amounts of C60-C90 fatty acids, mycolic acids, that are covalently linked to arabinogalactan.
Hiroshi Nikaido, Patrick J. Brennan
openaire   +2 more sources